Noninvasive risk stratification in unstable coronary artery disease: Exercise test and biochemical markers

American Journal of Cardiology

Volumn 80, Issue 5 A, 1997, Pages

  Lindahl, Bertil ^a   Andrén, Bertil ^a   Ohlsson, Jan ^b   Venge, Per ^a   Wallentin, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; TROPONIN I; TROPONIN T;

BICYCLE ERGOMETRY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; EXERCISE TEST; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT DEPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION; UNSTABLE ANGINA PECTORIS;

EID: 0030863392     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00489-X     Document Type: Conference Paper

References (33)

1. Braunwald E, Jones RH, Mark DB. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation. 90:1994;613-622.
2. Théroux P, Ouimet H, McCans J. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 319:1988;1105-1111.
3. Luchi RJ, Scott SM, Deupree R. Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. N Engl J Med. 316:1987;977-984.
4. Anderson HV, Cannon CP, Stone PH, Williams DO, Mccabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial - a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 26:1995;1643-1650.
5. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 326:1992;242-250.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 326:1992;310-318.
7. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 347:1996;561-568.
8. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 93:1996;1651-1657.
9. Lindahl B, Andrén B, Ohlsson J, Venge P, Wallentin L. Risk stratification in unstable coronary artery disease: additive value of troponin T determinations and predischarge exercise tests. Eur Heart J. 18:1997;762-770.
10. Swahn E, Andrén B, Nielsen N, Olsson J, Säfström KG, Wallentin L. The usefulness of pre-discharge exercise tests in women with unstable coronary artery disease (Abstr.). Eur Heart J. 16:1995;P1295.
11. Wilcox I, Freedman SB, Allman KC, Collins FL, Leitch JW, Kelly DT, Harris PJ. Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol. 18:1991;677-683.
12. Swahn E, Areskog M, Berglund U, Walfridsson H, Wallentin L. Predictive importance of clinical findings and a predischarge exercise test in patients with suspected unstable coronary disease. Am J Cardiol. 59:1987;208-214.
13. Launbjerg J, Fruergaard P, Jacobsen HL, Madsen JK. Long-term risk factors from non-invasive evaluation of patients with acute chest pain, but without myocardial infarction. Eur Heart J. 16:1995;30-37.
14. Nyman I, Wallentin L, Areskog M, Areskog NH, Swahn E. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. Int J Cardiol. 39:1993;131-142.
15. Juneau M, Colles P, Théroux P, de Guise P, Pelletier G, Lam J, Waters D. Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction. J Am Coll Cardiol. 20:1992;927-933.
16. Larsson H, Areskog M, Areskog NH, Nylander E, Nyman I, Swahn E, Wallentin L. Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction? Int J Card Imaging. 7:1991;7-14.
17. Swahn E, Areskog M, Wallentin L. Early exercise testing after coronary care for suspected unstable coronary artery disease - safety and diagnostic value. Eur Heart J. 7:1986;594-601.
18. Krone RJ, Gregory JJ, Freedland KE. Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: implications for management of stable coronary heart disease. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol. 24:1994;1274-1281.
19. Watanabe M, Yokota M, Miyahara T, Saito F, Matsunami T, Kodama Y, Saito H, Takeuchi J. Clinical significance of simple heart rate-adjusted ST-segment depression in supine leg exercise in the diagnosis of coronary artery disease. Am Heart J. 120:1990;1102-1110.
20. Sullivan AK, Holdright DR, Wright CA, Sparrow JL, Cunningham D, Fox KM. Chest pain in women: Clinical, investigative, and prognostic features. Br Med J. 308:1994;883-886.
21. Weiner DA, Ryan TJ, Parsons L, Fisher LD, Chaitman BR, Sheffield LT, Tristani FE. Long-term prognostic value of exercise testing in men and women from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol. 75:1995;865-870.
22. Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem. 28:1995;1-29.
23. Isakov A, Shapira I, Burke M, Almog C. Serum myoglobin levels in patients with ischemic myocardial insult. Arch Intern Med. 148:1988;1762-1765.
24. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, Noe A, Matern G, Kuebler W. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
25. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, Goldmann B, Katus HA. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 327:1992;146-150.
26. Markenvard J, Dellborg M, Jagenburg R, Swedberg K. The predictive value of CKMB mass concentration in unstable angina pectoris: preliminary report. J Intern Med. 231:1992;433-436.
27. Ravkilde J, Horder M, Gerhardt W. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest. 53:1993;677-685.
28. Pettersson T, Ohlsson O, Tryding N. Increased CKMB (mass concentration) in patients without traditional evidence of acute myocardial infarction. A risk indicator of coronary death. Eur Heart J. 13:1992;1387-1392.
29. Ravkilde J, Nissen H, Hörder M, Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction - analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol. 25:1995;574-581.
30. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BM J. 313:1996;262-264.
31. Wu AHB, Abbas SA, Green S, Pearsall L, Dhakam S, Azar R, Onoroski M, Senaie A, McKay RG, Waters D. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol. 76:1995;970-972.
32. de Winter RJ, Koster RW, Schotveld JH, Sturk A, van Straalen JP, Sanders GT. Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction. Heart. 75:1996;235-239.
33. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, Mccabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.